OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy
Meng Zhang, Yanmei Shi, Yujuan Zhang, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 6, pp. 951-967
Closed Access | Times Cited: 50
Meng Zhang, Yanmei Shi, Yujuan Zhang, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 6, pp. 951-967
Closed Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 51
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 51
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 46
Zhengjia Zhang, Qingcai Huang, Liuchunyang Yu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 46
CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
Hanghang Xie, Xiaowei Xi, Ting Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Hanghang Xie, Xiaowei Xi, Ting Lei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies
Aimi Syamima Abdul Manap, Aini Athirah Wisham, Fei Wen Wong, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Aimi Syamima Abdul Manap, Aini Athirah Wisham, Fei Wen Wong, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117899-117899
Closed Access | Times Cited: 65
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117899-117899
Closed Access | Times Cited: 65
Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines
Nastaran Hashemzadeh, Mitra Dolatkhah, Khosro Adibkia, et al.
Life Sciences (2021) Vol. 271, pp. 119110-119110
Closed Access | Times Cited: 49
Nastaran Hashemzadeh, Mitra Dolatkhah, Khosro Adibkia, et al.
Life Sciences (2021) Vol. 271, pp. 119110-119110
Closed Access | Times Cited: 49
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3691-3691
Open Access | Times Cited: 44
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3691-3691
Open Access | Times Cited: 44
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 19
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 19
Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
Faizah Alotaibi
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 16
Faizah Alotaibi
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 16
The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk‐Jarzynka, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6012-6012
Open Access | Times Cited: 39
Kuba Retecki, Milena Seweryn, Agnieszka Graczyk‐Jarzynka, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6012-6012
Open Access | Times Cited: 39
Regulatory networks of mRNAs and miRNAs involved in the immune response of diamondback moth, Plutella xylostella to fungal infection
Xie Meiqiong, Longjiang Wang, Huamei Xiao, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Xie Meiqiong, Longjiang Wang, Huamei Xiao, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
The power of microRNA regulation—insights into immunity and metabolism
Stefania Oliveto, Nicola Manfrini, Stefano Biffo
FEBS Letters (2025)
Open Access
Stefania Oliveto, Nicola Manfrini, Stefano Biffo
FEBS Letters (2025)
Open Access
Peptide-Based Vaccines in Clinical Phases and New Potential Therapeutic Targets as a New Approach for Breast Cancer: A Review
María Lilia Nicolás-Morales, Arianna Luisa-Sanjuan, Mayralina Gutiérrez-Torres, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1249-1249
Open Access | Times Cited: 19
María Lilia Nicolás-Morales, Arianna Luisa-Sanjuan, Mayralina Gutiérrez-Torres, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1249-1249
Open Access | Times Cited: 19
A Novel Engineered AAV-Based Neoantigen Vaccine in Combination with Radiotherapy Eradicates Tumors
Kevin Chih‐Yang Huang, Chia-Ying Lai, Wei-Ze Hung, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 1, pp. 123-136
Open Access | Times Cited: 19
Kevin Chih‐Yang Huang, Chia-Ying Lai, Wei-Ze Hung, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 1, pp. 123-136
Open Access | Times Cited: 19
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
Huiling Zhou, Wentao Jia, Lingeng Lu, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 824-824
Open Access | Times Cited: 11
Huiling Zhou, Wentao Jia, Lingeng Lu, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 824-824
Open Access | Times Cited: 11
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
Xiangfei Su, Mi Zhang, Hong Zhu, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Xiangfei Su, Mi Zhang, Hong Zhu, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
Effects of light exposure during IVF: transcriptomic analysis of murine embryos and embryo-derived EVs
Bence Nagy, Zoltán Bognár, Tímea Csabai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bence Nagy, Zoltán Bognár, Tímea Csabai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Differential RNA packaging into small extracellular vesicles by neurons and astrocytes
Xuan Luo, Renée Jean‐Toussaint, Ahmet Saçan, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Xuan Luo, Renée Jean‐Toussaint, Ahmet Saçan, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 25
MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer
Eunsun Jung, Jinhyeon Choi, Jang-Seong Kim, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 136-136
Open Access | Times Cited: 24
Eunsun Jung, Jinhyeon Choi, Jang-Seong Kim, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 136-136
Open Access | Times Cited: 24
Circ_ZFR affects FABP7 expression to regulate breast cancer progression by acting as a sponge for miR ‐223‐3p
Xiuling Tian, Hong Yang, Fang Qian, et al.
Thoracic Cancer (2022) Vol. 13, Iss. 9, pp. 1369-1380
Open Access | Times Cited: 16
Xiuling Tian, Hong Yang, Fang Qian, et al.
Thoracic Cancer (2022) Vol. 13, Iss. 9, pp. 1369-1380
Open Access | Times Cited: 16
CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts
Faizah Alotaibi, Wei‐Ping Min, James Koropatnick
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Faizah Alotaibi, Wei‐Ping Min, James Koropatnick
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
CD8+ T-cell exhaustion: Impediment to triple-negative breast cancer (TNBC) immunotherapy
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189193-189193
Closed Access | Times Cited: 3
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189193-189193
Closed Access | Times Cited: 3
The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications
Priya Mondal, Bhavjot Kaur, Jagadish Natesh, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 99-113
Closed Access | Times Cited: 21
Priya Mondal, Bhavjot Kaur, Jagadish Natesh, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 99-113
Closed Access | Times Cited: 21
